ADIPOQ and Paroxysmal atrial fibrillation: Accordingly, these studies suggest that despite some observational studies indicating a direct relationship between adiponectin and higher risk of AF in a population‐based cohort (Macheret et al., 2015) and after catheter ablation in patients with paroxysmal AF (Kim et al., 2017), this peptide may modulate pathophysiological pathways in AF.